Care4Nature Holding ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  4.6% 5.3% 2.7% 2.5% 1.7%  
Credit score (0-100)  46 40 60 61 73  
Credit rating  BBB BBB BBB BBB A  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 1.4  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12

Net sales  0 0 0 0 0  
Gross profit  -8.0 -14.7 -14.3 -21.9 -17.5  
EBITDA  -8.0 -14.7 -14.3 -21.9 -17.5  
EBIT  -8.0 -14.7 -14.3 -21.9 -17.5  
Pre-tax profit (PTP)  87.9 180.5 439.3 393.2 553.9  
Net earnings  89.9 141.3 450.9 416.7 530.9  
Pre-tax profit without non-rec. items  87.9 180 439 393 554  

 
See the entire income statement

Balance sheet (kDKK) 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12

Tangible assets total  0.0 0.0 0.0 0.0 0.0  
Shareholders equity total  658 686 1,022 1,321 1,537  
Interest-bearing liabilities  145 0.2 163 50.8 621  
Balance sheet total (assets)  880 874 1,193 1,385 2,196  

Net Debt  61.4 -81.6 -224 -552 -854  
 
See the entire balance sheet

Volume 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  -8.0 -14.7 -14.3 -21.9 -17.5  
Gross profit growth  47.4% -82.6% 2.4% -53.2% 20.4%  
Employees  0 0 0 0 0  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  880 874 1,193 1,385 2,196  
Balance sheet change%  10.3% -0.7% 36.5% 16.1% 58.5%  
Added value  -8.0 -14.7 -14.3 -21.9 -17.5  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 0 0 0 0  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  -4.0 -5.0 -5.0 -5.0 -5.0  

Profitability 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  100.0% 100.0% 100.0% 100.0% 100.0%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  11.0% 21.4% 47.1% 37.4% 31.7%  
ROI %  12.4% 25.2% 52.1% 37.7% 32.2%  
ROE %  13.5% 21.0% 52.8% 35.6% 37.1%  

Solidity 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Equity ratio %  74.7% 78.5% 85.7% 95.4% 70.0%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -764.4% 556.7% 1,567.0% 2,517.6% 4,892.8%  
Gearing %  22.1% 0.0% 15.9% 3.8% 40.4%  
Net interest  0 0 0 0 0  
Financing costs %  5.4% 9.7% 58.9% 83.2% 4.3%  

Liquidity 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Quick Ratio  1.3 1.6 3.6 12.6 2.5  
Current Ratio  1.3 1.6 3.6 12.6 2.5  
Cash and cash equivalent  84.0 81.8 386.7 602.4 1,474.9  

Capital use efficiency 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  76.4 66.5 72.1 151.5 -398.0  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 0 0 0  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 0 0 0  
EBIT / employee  0 0 0 0 0  
Net earnings / employee  0 0 0 0 0